Stay updated on Magrolimab in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.

Latest updates to the Magrolimab in Hematological Malignancies Clinical Trial page
- Check4 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4. This indicates a minor patch to the page's versioning rather than a substantive content update.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a new revision tag Revision: v3.6.3, replacing the previous Revision: v3.6.0. The change appears to be a minor page version update and does not affect the study details.SummaryDifference0.0%

- Check47 days agoChange DetectedRecruitment is now marked as closed ('No longer looking for participants'), signaling that the study is not accepting new participants. The changes also add navigation/help items (How to Read a Study Record, Common Questions, How to Join a Study) and adjust the Intervention/Treatment heading formatting, with the footer revision tag updated to v3.6.0.SummaryDifference0.4%

- Check54 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, representing a new version of the page rather than a substantive change to study information.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a maintenance or template update rather than changes to the study details.SummaryDifference0.0%

- Check97 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.0** to **v3.5.3**, indicating a site release/version change without altering the clinical trial’s study details.SummaryDifference0.0%

Stay in the know with updates to Magrolimab in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.